13, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood ...
CytoSorbents (CTSO) Corporation announced that the Company closed the subscription period of its previously announced rights offering at 5:00 PM EST on January 10, 2025. The Company raised ...
StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a report released on Monday. The firm issued a hold rating on the medical research company’s stock.